213 related articles for article (PubMed ID: 10678972)
21. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
[TBL] [Abstract][Full Text] [Related]
22. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
Landers CJ; Cohavy O; Misra R; Yang H; Lin YC; Braun J; Targan SR
Gastroenterology; 2002 Sep; 123(3):689-99. PubMed ID: 12198693
[TBL] [Abstract][Full Text] [Related]
23. pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis.
Gordon LK; Eggena M; Holland GN; Weisz JM; Braun J
J Clin Immunol; 1998 Jul; 18(4):264-71. PubMed ID: 9710743
[TBL] [Abstract][Full Text] [Related]
24. Mucosa-associated bacterial flora of the human colon.
Poxton IR; Brown R; Sawyerr A; Ferguson A
J Med Microbiol; 1997 Jan; 46(1):85-91. PubMed ID: 9003751
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
26. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.
Bamba T; Matsuda H; Endo M; Fujiyama Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():45-7. PubMed ID: 8563888
[TBL] [Abstract][Full Text] [Related]
27. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies.
Billing P; Tahir S; Calfin B; Gagne G; Cobb L; Targan S; Vidrich A
Am J Pathol; 1995 Oct; 147(4):979-87. PubMed ID: 7573373
[TBL] [Abstract][Full Text] [Related]
28. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis.
Eggena M; Targan SR; Iwanczyk L; Vidrich A; Gordon LK; Braun J
J Immunol; 1996 May; 156(10):4005-11. PubMed ID: 8621942
[TBL] [Abstract][Full Text] [Related]
29. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis.
Lee JH; Cheon JH; Kim ES; Chung MJ; Kang W; Kim DH; Ha YJ; Park JJ; Kim TI; Kim WH
Dig Dis Sci; 2010 May; 55(5):1406-12. PubMed ID: 19507028
[TBL] [Abstract][Full Text] [Related]
30. Ocular pANCA antigens are expressed in nonpigmented ciliary body epithelium and are conserved in multiple mammalian species.
Sandusky H; Cilluffo M; Braun J; Gordon LK
Ocul Immunol Inflamm; 2001 Mar; 9(1):25-34. PubMed ID: 11262665
[TBL] [Abstract][Full Text] [Related]
31. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
[TBL] [Abstract][Full Text] [Related]
32. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease.
Mei L; Targan SR; Landers CJ; Dutridge D; Ippoliti A; Vasiliauskas EA; Papadakis KA; Fleshner PR; Rotter JI; Yang H
Gastroenterology; 2006 Apr; 130(4):1078-85. PubMed ID: 16618402
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
[TBL] [Abstract][Full Text] [Related]
34. Serological markers predict inflammatory bowel disease years before the diagnosis.
van Schaik FD; Oldenburg B; Hart AR; Siersema PD; Lindgren S; Grip O; Teucher B; Kaaks R; Bergmann MM; Boeing H; Carbonnel F; Jantchou P; Boutron-Ruault MC; Tjønneland A; Olsen A; Crowe FL; Peeters PH; van Oijen MG; Bueno-de-Mesquita HB
Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to Escherichia coli 06 porins cross-react with urinary pathogens.
Kawahara M; Human LG; Winningham JS; Domingue GJ
Immunobiology; 1994 Dec; 192(1-2):65-76. PubMed ID: 7538488
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
[TBL] [Abstract][Full Text] [Related]
38. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
[TBL] [Abstract][Full Text] [Related]
39. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
[TBL] [Abstract][Full Text] [Related]
40. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
Vidrich A; Lee J; James E; Cobb L; Targan S
J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
